Pancreas Transplant

Introduction

If you are living with long-standing type 1 diabetes — perhaps with kidney problems, dangerous low blood sugar episodes, or complications that no longer respond well to insulin and lifestyle measures — you may have been told that a pancreas transplant could be an option. This guide is written for people who are exploring that path, who have been referred for transplant assessment, or who are already on a waiting list and want to understand what lies ahead.

A pancreas transplant is a major operation. It is not a treatment for type 2 diabetes in most cases, and it is not the first step in managing diabetes. It is considered for a specific group of people in whom the risks of severe diabetes complications outweigh the risks of surgery and lifelong immunosuppression. For those carefully selected patients, a successful transplant can restore the body’s own ability to make insulin and bring blood sugar back into a normal range without injections.

This article explains what the surgery involves, who it is suitable for, the different types of pancreas transplant, what to expect during recovery, the medicines you will need afterwards, the risks involved, and what life can look like in the months and years that follow.

What Is a Pancreas Transplant?

A pancreas transplant is a surgical procedure in which a healthy pancreas from a deceased donor is placed into a person whose own pancreas no longer produces enough insulin to control blood sugar. The donor pancreas is connected to the recipient’s blood vessels and to a part of the intestine (or, less commonly, the bladder) so that its digestive enzymes can drain away. The recipient’s own pancreas is usually left in place because it still produces digestive enzymes that the body needs.

The pancreas has two main jobs. It produces digestive enzymes that help break down food in the intestine, and it produces hormones — most importantly insulin and glucagon — that regulate blood sugar. In type 1 diabetes, the immune system destroys the insulin-producing cells (called beta cells) inside the pancreas. The rest of the pancreas usually continues to work, so digestion is not affected, but blood sugar control depends entirely on injected insulin. A successful pancreas transplant restores the body’s own insulin production, which can stabilise blood sugar in a way that even the best insulin therapy sometimes cannot match.

It is important to understand from the outset that a pancreas transplant replaces insulin injections with something equally lifelong: immunosuppressive medication. These are drugs that prevent the body from rejecting the new organ. They must be taken every day, indefinitely, and they carry their own risks. The decision to transplant is therefore a trade between the burden and risks of diabetes and the burden and risks of immunosuppression.

Why Is a Pancreas Transplant Performed?

Most pancreas transplants are performed for people with type 1 diabetes whose disease has either caused serious complications or become very difficult to manage safely. The most common reasons include:

• Kidney failure caused by diabetes. Long-standing diabetes can damage the kidneys (diabetic nephropathy). When kidney function fails, a kidney transplant is needed. In many of these patients, a pancreas is transplanted at the same time, which both restores insulin production and protects the new kidney from future diabetic damage.
• Hypoglycaemia unawareness. Some people with long-standing type 1 diabetes lose the early warning symptoms of low blood sugar. They can become severely hypoglycaemic without warning, leading to falls, seizures, accidents, or coma. This is a recognised indication for transplant when it cannot be controlled with insulin pumps and continuous glucose monitoring.
• Brittle or labile diabetes. A pattern of very unstable blood sugar — frequent dangerous highs and lows despite expert care — that disrupts life and threatens health.
• Progressive diabetic complications in someone whose current medical management is not working well enough, including severe diabetic eye, nerve, or blood vessel disease.

Pancreas transplant is rarely the right answer for type 2 diabetes, because the underlying problem in type 2 is often insulin resistance rather than a lack of insulin production, and most people with type 2 diabetes also have cardiovascular and other risks that make major surgery less safe. A small number of carefully selected people with insulin-dependent type 2 diabetes have had pancreas transplants, usually together with a kidney transplant, but this remains uncommon.

Pancreas transplant is also occasionally considered after total pancreatectomy (surgical removal of the entire pancreas) for non-cancer conditions such as chronic pancreatitis, although islet cell transplantation is more commonly used in that situation.

Who Is a Candidate?

Whether a pancreas transplant is appropriate for a particular person is a clinical decision made by a transplant team after careful evaluation. Transplant centres generally look at the following:

• Type and severity of diabetes. Most commonly type 1 diabetes with significant complications or unstable control.
• Kidney function. Whether kidneys are healthy, failing, or already failed influences which type of transplant is offered.
• Heart and blood vessel health. Because diabetes affects the heart and arteries, a thorough cardiac evaluation is essential. Severe untreated heart disease can make transplant too risky.
• Active infection or cancer. Most active infections must be treated first, and most recent cancers must be in remission for a defined period before transplant.
• Body weight. Very high body mass index can increase surgical risk and is sometimes a reason to delay listing.
• Psychological readiness and support. Transplant requires lifelong daily medication, frequent appointments, and significant lifestyle adjustments. Mental health and social support are assessed.
• Ability to tolerate immunosuppression. Some medical conditions make lifelong immunosuppression too dangerous.

Age limits are not absolute. Younger patients tend to tolerate surgery better, but carefully selected older adults are also transplanted at many centres. Pancreas transplant is very rarely performed in children — it is almost entirely an adult procedure — because the long-term burden of immunosuppression is generally felt to outweigh the benefit in children with type 1 diabetes, who can usually be managed with insulin pumps and continuous glucose monitoring.

Types of Pancreas Transplant

Simultaneous Pancreas-Kidney Transplant (SPK)

In an SPK transplant, the pancreas and a kidney from the same deceased donor are transplanted into the recipient during a single operation. This is the most common type of pancreas transplant worldwide. It is offered to people who have both type 1 diabetes and kidney failure (or near-failure).

The advantage of SPK is that one operation, one donor, and one course of immunosuppression cover both organs. Long-term outcomes for SPK are generally the best of the three types, partly because the kidney provides an early warning system for rejection — rejection of the pancreas alone can be hard to detect, but a rising creatinine from the kidney is easy to measure.

Pancreas After Kidney Transplant (PAK)

In a PAK transplant, a person who has already received a kidney transplant (often from a living donor) later receives a pancreas from a deceased donor. This is appropriate when a living kidney donor was available and used first to address kidney failure quickly, with the pancreas added afterwards once the patient has recovered.

PAK avoids the long wait for a combined deceased-donor offer, but it does involve two separate operations and two separate recoveries. Long-term pancreas survival in PAK is generally slightly lower than in SPK, but it remains a valuable option.

Pancreas Transplant Alone (PTA)

PTA is offered to people who have type 1 diabetes with severe complications — usually disabling hypoglycaemia unawareness or extremely unstable blood sugar — but whose kidney function is still good enough that they do not need a kidney transplant. PTA is the least common type because patients have to accept lifelong immunosuppression purely to gain insulin independence, and the trade-off must be carefully weighed.

Beyond these three types, almost all pancreas transplants come from deceased donors. Living-donor pancreas transplant (where a healthy person donates a portion of their pancreas) has been done in very limited numbers historically but is rare in current practice.

Alternatives to Consider

Pancreas transplant is one option among several for severe type 1 diabetes. Most people will have tried, or be on, one or more of the following before transplant is considered:

• Intensive insulin therapy with a continuous glucose monitor (CGM) and insulin pump. Modern hybrid closed-loop systems — sometimes called “artificial pancreas” systems — combine a CGM with an insulin pump that adjusts insulin delivery automatically. For many people, these systems substantially reduce both high and low blood sugar episodes and remove the need to consider transplant.
• Islet cell transplantation. Instead of transplanting the whole pancreas, isolated insulin-producing islet cells from a donor pancreas are infused into the liver, where they take up residence and begin producing insulin. This is a smaller procedure with lower surgical risk, but it still requires immunosuppression, and the duration of insulin independence has historically been shorter than with whole-organ pancreas transplant. Availability of islet transplantation varies by country and centre.
• Optimised medical management with a specialist diabetes team, including structured education, dietitian input, and regular follow-up. For some patients, returning to a highly specialised diabetes service with the latest technology resolves the problems that prompted the transplant referral.
• Kidney transplant alone for people with type 1 diabetes and kidney failure who are not suitable for a pancreas transplant. Diabetes management continues with insulin, but kidney function is restored.

Whether one of these alternatives is more appropriate than a pancreas transplant is a decision for the patient and their transplant and diabetes teams together. Major transplant societies recommend that all reasonable alternatives be considered before listing for pancreas transplant.

Preparing for Surgery

Once a transplant team agrees that a pancreas transplant is appropriate, you will go through a detailed evaluation before being placed on the waiting list.

Recipient Assessment

Evaluation usually includes:

• Blood tests, including blood group, tissue typing (HLA), and tests for previous exposure to viruses such as cytomegalovirus, Epstein-Barr virus, hepatitis B and C, HIV, and others
• Kidney function tests
• Detailed cardiac assessment — often including ECG, echocardiogram, and stress testing or coronary angiography, because heart disease is common in long-standing diabetes
• Imaging of the abdomen and pelvis to plan the surgery
• Dental and general infection screening
• Cancer screening appropriate to age and sex
• Psychological and social assessment
• Dietitian and diabetes nurse review

Waiting for a Donor

Most pancreas transplants use organs from deceased donors. After listing, the wait can vary from weeks to many months depending on blood group, tissue match, body size, and local organ availability. During this time, the team will keep your assessment up to date with periodic blood tests and reviews.

When a suitable donor pancreas becomes available, you will be called in urgently — sometimes at very short notice. You will be asked not to eat or drink, and final cross-matching tests will be done to confirm compatibility.

Practical Preparation

People preparing for transplant are usually advised to:

• Stop smoking, as smoking worsens surgical risk and long-term outcomes
• Keep blood sugar as stable as possible
• Maintain a healthy weight
• Stay as physically active as their condition allows
• Keep all vaccinations up to date before transplant, because some live vaccines cannot be given once immunosuppression starts
• Arrange for someone to support them through surgery and the early recovery period

What Happens During Surgery

Pancreas transplant is performed under general anaesthesia. You will be asleep throughout and will not feel or remember the operation. The surgery typically takes 4 to 6 hours for a pancreas transplant alone, and longer if a kidney is being transplanted at the same time.

The surgeon makes an incision in the lower abdomen. The donor pancreas is placed in the pelvis or lower abdomen rather than in the original position of your own pancreas. This is because the original location is difficult to reach surgically and because the new position allows easier connection to large blood vessels.

The key steps are:

1. Connection to blood vessels. The artery and vein of the donor pancreas are joined to your own blood vessels — usually the iliac vessels in the pelvis — so that blood flows through the new organ.
2. Drainage of digestive enzymes. The donor pancreas comes with a short piece of small intestine (called the duodenal segment). The surgeon connects this to your own small intestine so that the digestive enzymes the new pancreas continues to produce can drain away normally. In some centres, the drainage is instead routed to the bladder; enteric (intestinal) drainage is now the more common technique.
3. If a kidney is also being transplanted (SPK), the donor kidney is placed on the other side of the pelvis and connected to your blood vessels and bladder.

Recovery in Hospital

After surgery, you will be moved to an intensive care unit (ICU) or high-dependency unit for close monitoring. The ICU stay is typically 2 to 5 days. Total hospital stay is commonly 2 to 3 weeks, though this varies with the type of transplant and any complications.

During this phase the team monitors:

• Blood sugar levels, which often normalise quickly — sometimes within the first day
• Pancreatic enzyme levels (amylase and lipase) in blood and, if a drain is in place, in drain fluid
• Kidney function, especially after SPK
• Signs of rejection, infection, or bleeding
• Blood flow through the new pancreas, usually with regular ultrasound scans
• Pain control and recovery of bowel function

Immunosuppressive medications are started immediately, often beginning during the operation itself. Typical regimens combine an induction medicine (used only in the first days) with longer-term maintenance drugs such as tacrolimus, mycophenolate, and sometimes a low dose of a steroid. The exact combination is decided by the transplant team based on your situation.

You will gradually move from intravenous fluids and pain medicines to eating and drinking normally, then to sitting up, walking, and self-care. Insulin is usually stopped as the new pancreas takes over — this transition is closely watched.

Recovery at Home

Once you are discharged, the first three months are the most intensive period of recovery and monitoring.

The First Month

Expect frequent clinic visits — sometimes two or three times a week early on — for blood tests, ultrasound scans, and review of medication levels. The dose of immunosuppression has to be carefully balanced: too little and the body may reject the transplant, too much and you become more vulnerable to infection and side effects. Light activity is encouraged, but heavy lifting, driving, and strenuous exercise are usually restricted for several weeks while the wound heals.

Months Two and Three

Strength returns gradually. Most people are able to resume desk-based work and normal daily activities by around two to three months, although the timeline depends on your overall fitness and how the surgery went. Clinic visits become less frequent. Blood sugar is checked regularly to confirm that the new pancreas is working well.

Beyond Three Months

Risks and Complications

Pancreas transplant is a major operation and carries real risks. Your transplant team will discuss these in detail; the most important ones include:

Surgical Complications

• Bleeding during or after the operation, sometimes needing a return to the operating room
• Blood clots (thrombosis) in the vessels supplying the new pancreas, which can cause the transplant to fail. This is one of the most important early complications and is the reason for very close monitoring with ultrasound in the first days.
• Leakage from the connection between the donor duodenum and your intestine or bladder
• Infection of the wound or inside the abdomen
• Pancreatitis in the new pancreas, often mild and self-limiting but occasionally serious
• Need for repeat surgery to deal with bleeding, leaks, or clots

Rejection

Even with immunosuppression, the immune system can recognise the new pancreas as foreign and attack it. Rejection is most common in the first year but can happen at any time. It is often treatable if caught early — usually by increasing or changing immunosuppression — which is why regular monitoring is so important. In SPK transplants, rejection of the kidney is easier to detect early than rejection of the pancreas, which is one of the practical advantages of doing the two together.

Risks from Immunosuppression

The drugs that protect the transplant also affect the rest of the body. Common longer-term issues include:

• Increased risk of infections, including some unusual ones
• Increased risk of certain cancers over time, especially skin cancers
• Kidney strain — some immunosuppressants are themselves hard on the kidneys
• High blood pressure
• Changes in cholesterol and lipid levels
• Tremor, hair changes, or gum changes depending on the specific medication
• Increased risk of new diabetes in some patients due to immunosuppressive drugs — an unwelcome irony that the transplant team monitors for

Graft Failure

The new pancreas does not last forever in every patient. Some grafts fail in the first year due to clots, rejection, or technical problems. Others fail gradually over many years. If the transplanted pancreas stops working, insulin therapy is resumed, and in some cases a second transplant is considered.

Outcomes and Success Rates

Pancreas transplant outcomes have improved substantially over the past two decades thanks to better surgical technique, more effective immunosuppression, and better selection of candidates and donors. In experienced transplant centres, most pancreas grafts are functioning at one year, and long-term insulin independence is achieved by a large proportion of recipients.

Outcomes vary by type of transplant. Simultaneous pancreas-kidney transplant generally has the best long-term graft survival, followed by pancreas after kidney, with pancreas transplant alone showing somewhat lower long-term graft survival but still meaningful benefit for carefully selected patients.

It is worth being honest about what “success” means here. A successful pancreas transplant typically delivers:

• Freedom from insulin injections
• Normal or near-normal blood sugar levels without daily titration
• Resolution of severe hypoglycaemia and hypoglycaemia unawareness
• Stabilisation, and sometimes partial improvement, of some long-term diabetic complications such as nerve damage
• Significant improvements in quality of life for most recipients

It does not typically reverse advanced complications that are already established — for example, severe diabetic eye disease or advanced nerve damage is unlikely to disappear. It also does not remove the need for daily medication; it replaces insulin with immunosuppressants.

For personalised outcome estimates, your transplant team can review your specific situation — age, type of transplant being considered, kidney function, heart health, and other factors — and discuss what is realistic in your case.

Life After a Pancreas Transplant

Medications

You will take immunosuppressive medication every day for as long as the transplant is functioning. Doses and combinations may be adjusted over time, but stopping these medicines abruptly almost always leads to rejection. You will also typically take medicines to prevent infections in the first months (for example, against cytomegalovirus and pneumocystis), and possibly medicines to control blood pressure or cholesterol.

Diet and Lifestyle

After a successful transplant, most people no longer need a diabetic diet in the strict sense. However, a generally healthy, balanced diet is important to protect the new organ, the heart, and the kidneys. Specific points often emphasised by transplant teams include:

• Food safety: avoid raw or undercooked meat, eggs, and seafood, and unpasteurised dairy, because immunosuppression raises the risk of foodborne infection
• Moderate salt intake to help control blood pressure
• Limit alcohol
• Maintain a healthy weight
• Avoid grapefruit and grapefruit juice, which interact with some immunosuppressants

Regular, moderate physical activity is encouraged once the wound has healed. Many transplant recipients return to walking, cycling, swimming, and other activities they enjoyed before.

Sun Protection

Skin cancer risk is higher on long-term immunosuppression. Daily sun protection, including sunscreen and protective clothing, and regular skin checks are important.

Vaccinations and Travel

Vaccinations need to be planned with your transplant team. Live vaccines are generally avoided once you are on immunosuppression. Travel is possible — many transplant recipients travel internationally — but it needs planning, including making sure you have enough medication, knowing how to access healthcare at your destination, and avoiding food and water risks.

Emotional and Practical Adjustment

The first months after transplant can be emotionally complex. Relief at not injecting insulin is often mixed with anxiety about rejection, the demands of new medications, and adjustment to a body that feels different. Speaking openly with your transplant team, with family, and where helpful with a psychologist or peer support group, is part of looking after the transplant well.

Long-Term Follow-Up

Lifelong follow-up is part of having a transplant. The pattern is intensive in the first year, then settles into less frequent but continuing reviews. Typical components include:

• Regular blood tests for blood sugar, HbA1c, pancreatic enzymes, kidney and liver function, and immunosuppression drug levels
• Periodic urine tests
• Periodic imaging of the transplant
• Cardiovascular risk monitoring (blood pressure, cholesterol)
• Cancer screening, especially of the skin
• Dental and eye reviews
• Vaccination updates

For patients who travel for transplant surgery, follow-up is usually shared between the transplant centre and a local team near home, with the transplant centre remaining involved in the overall plan. Teleconsultations have made this kind of shared care more practical.

Frequently Asked Questions

Can a pancreas transplant cure type 1 diabetes?

A successful pancreas transplant restores the body’s own insulin production, and most recipients no longer need insulin injections. In that practical sense, diabetes is reversed. However, the transplant has to be protected by lifelong immunosuppression, and if the graft eventually fails, insulin therapy resumes. So while it is a powerful treatment, it is not a cure in the sense of going back to never having had diabetes.

Will I be free of insulin immediately after surgery?

Often yes. Many recipients see their blood sugar normalise within hours to days of the new pancreas being connected. The transplant team monitors this carefully and stops insulin once the new organ is clearly taking over.

Why do I still need medications if the transplant is successful?

The immune system will always recognise the new pancreas as foreign tissue and try to attack it. Immunosuppressive medications keep this response in check. They cannot be stopped, because doing so almost always leads to rejection and loss of the transplant.

Is a pancreas transplant ever done for type 2 diabetes?

Only in a small number of carefully selected patients, usually together with a kidney transplant. The decision depends on the underlying biology of the patient’s diabetes, their overall health, and the judgment of the transplant team.

What is the difference between SPK, PAK, and PTA?

SPK (simultaneous pancreas-kidney) means pancreas and kidney are transplanted at the same time, from the same donor. PAK (pancreas after kidney) means a kidney was transplanted first, often from a living donor, and the pancreas is added later. PTA (pancreas transplant alone) means only the pancreas is transplanted, in someone whose kidneys still work well. SPK is the most common and generally has the best long-term outcomes.

How long does a pancreas transplant last?

This varies. Many transplants function well for many years, particularly SPK transplants. Some fail in the early months because of complications such as clots or rejection. Long-term survival depends on the type of transplant, how closely the patient follows medication and monitoring, and individual factors.

What happens if the transplant fails?

If the transplanted pancreas stops working, insulin therapy is restarted. Depending on the reason for failure and the patient’s overall health, a second transplant may be considered. The transplant team will discuss options carefully.

Can I have children after a pancreas transplant?

Pregnancy is possible after a pancreas transplant but is considered high-risk and needs careful planning with the transplant and obstetric teams. Some immunosuppressive medications must be changed before pregnancy, and timing is usually delayed until the transplant has been stable for at least a year or two.

How is rejection detected?

Rejection of the pancreas can be subtle. Rising blood sugar is a late sign — by then the damage may already be substantial. Earlier signs include rising pancreatic enzyme levels, changes on ultrasound, or, in SPK, changes in kidney function. This is why regular blood tests and clinic visits are so important.

What should I look for in a transplant centre?

Useful things to consider include the centre’s experience with pancreas transplant (volumes performed), the presence of a multidisciplinary team (transplant surgeons, transplant physicians, diabetes specialists, nephrologists, intensive care, transplant nursing, dietitians, psychologists), 24-hour intensive care capacity, and a structured follow-up programme. Meeting the team and asking questions before committing is reasonable.

Conclusion

A pancreas transplant is a serious operation with the potential to transform daily life for selected people with severe type 1 diabetes — particularly those whose kidneys have failed, who suffer dangerous hypoglycaemia, or whose blood sugar cannot be controlled safely with current medical therapy. Most recipients of a successful transplant achieve insulin independence and a level of metabolic stability that injected insulin alone often cannot match.

It is also a lifelong commitment. The new pancreas must be protected with daily immunosuppressive medication, regular monitoring, and careful attention to health risks such as infection and certain cancers. The decision to pursue transplant, and the choice between SPK, PAK, and PTA, is made together with a specialist transplant team after a thorough assessment of the diabetes, the kidneys, the heart, and the person as a whole.

For patients and families exploring this path, the most useful next step is a detailed conversation with a transplant centre, where individual risks, expected benefits, and the realistic shape of life after transplant can be discussed in the context of your own medical history.